C5AR-ANTAGONISTEN

European patent · EP2381778 · In force

Register entry

Publication number
EP2381778
Application number
EP09835688
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 21, 2009
Published
Nov 2, 2011
Granted
Jun 8, 2016
Protection ends at the latest
Dec 20, 2029
Next annual fee due
Dec 31, 2026
IPC classes
C07D 211/60 (2006.01)
C07D 401/06 (2006.01)
C07D 401/10 (2006.01)
C07D 401/14 (2006.01)
C07D 405/10 (2006.01)
C07D 413/12 (2006.01)
A61P 37/06 (2006.01)
A61K 31/445 (2006.01)
A61K 31/451 (2006.01)
A61K 31/4545 (2006.01)
A61K 31/5377 (2006.01)
Priority
US 139919 P 22.12.2008
PCT application
PCT/US2009/068941 21.12.2009
PCT publication
WO2010/075257 01.07.2010
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Avacopanum

C02381778/01 · Medicine · Granted · Protection from Dec 21, 2029 to Dec 20, 2034

Authorisation 66772 (Swissmedic, Sep 19, 2022)

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. May 23, 2023

    Corrected

    Owner
    ChemoCentryx, Inc., One Amgen Drive, Thousand Oaks, CA 91320, USA → ChemoCentryx, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA

    Published in Swissreg on 23.05.2023

  5. May 15, 2023

    Address changed

    Owner
    ChemoCentryx, Inc., 835 Industrial Road Suite 600, San Carlos CA 94070, USA → ChemoCentryx, Inc., One Amgen Drive, Thousand Oaks, CA 91320, USA

    Published in Swissreg on 15.05.2023

  6. Jan 10, 2023

    Change

    Published in Swissreg on 10.01.2023

  7. May 9, 2022

    Agent removed

    Representative
    OFFICE ERNEST T. FREYLINGER S.A., c/o SCHLUEP & DEGEN, P.O. BOX 8062, 3001 Bern (removed)

    Published in Swissreg on 09.05.2022

  8. May 9, 2022

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 09.05.2022

3 earlier entries
  1. May 9, 2022

    Address changed

    Owner
    ChemoCentryx, Inc., 850 Maude Avenue, Mountain View, California 94043, USA → ChemoCentryx, Inc., 835 Industrial Road Suite 600, San Carlos CA 94070, USA

    Published in Swissreg on 09.05.2022

  2. Jul 14, 2016

    Agent entered

    Representative
    OFFICE ERNEST T. FREYLINGER S.A., c/o SCHLUEP & DEGEN, P.O. BOX 8062, 3001 Bern

    Published in Swissreg on 14.07.2016

  3. Jun 8, 2016

    Granted

    Published in Swissreg on 08.06.2016

Parties

Holder

ChemoCentryx, Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320, US

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

FAN, Pingchen

Fremont California 94539, US

GREENMAN, Kevin Lloyd

Sunnyvale California 94086, US

LELETI, Manmohan Reddy

Cupertino California 95014, US

LI, Yandong

San Jose California 95127, US

POWERS, Jay

Pacifica California 94044, US

TANAKA, Hiroko

Foster City California 94404, US

YANG, Ju

Cupertino California 95014, US

ZENG, Yibin

Foster City California 94404, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.